Investment & Market Trends

Investment & Market Trends

Citi Plans to Increase Investment Banking Staff in Japan by Up to 15%

HONG KONG – Citigroup plans to grow its investment banking workforce in Japan by 10% to 15% over the next year and make additional hires in Australia, as part of its broader strategy to scale up in the Asia Pacific, said its regional investment banking head. The expansion comes on the back of surging interest in cross-border mergers and acquisitions (M&A) in Japan, where Citi’s investment banking fees have jumped 140% to US$92 million as of July 10, compared to the same period last year, according to Dealogic data. “We’re making significant investments in strengthening our regional investment banking team,” said Jan Metzger, Citi’s Asia Pacific head of investment banking. “We’re targeting high-growth markets and aiming to outpace that growth.” Citi did not break down headcount plans by market, but Metzger noted that Japan will be a key focus due to ongoing corporate governance reforms, regulatory encouragement for companies to enhance market value, and a robust pipeline of advanced tech capabilities. The bank recently advised Nippon Steel on its US$14.9 billion acquisition of U.S. Steel, a deal Metzger says has sparked increased client interest. “Our phones have been ringing non-stop from companies looking to navigate complex geopolitical transactions,” he added. Citi has already strengthened its Asia team with senior hires this year, including Akira Kiyota from Nomura in Japan and Philippe Perzi, a former Goldman Sachs banker, in Australia. Globally, Citi saw a 13% rise in investment banking fees in the second quarter of 2025. Deal Momentum Builds in Japan and Australia Japan is leading Asia’s M&A recovery this year, recording US$232 billion in deals in the first half of 2025. Bankers expect the momentum to continue, driven by take-private deals, outbound M&A, and growing private equity activity. In Australia, an uptick in international deal activity is giving global banks an advantage over boutique advisory firms. Metzger said Citi’s full-service banking offering enhances its competitiveness in the Australian market. Another growth area for Citi in Asia is convertible bond issuance. The bank recently helped Alibaba raise HK$12 billion (US$1.5 billion) through an exchangeable bond deal. Investor demand for convertible bonds has risen, particularly from Chinese tech firms, as they provide downside protection amid geopolitical uncertainty, Metzger noted.

Investment & Market Trends

Ambani’s Jio Partners with Allianz to Launch Reinsurance Venture in India

Jio Financial Services Ltd, part of Mukesh Ambani’s business empire, has entered into a 50:50 joint venture with global insurer Allianz SE to establish a reinsurance business in India. The partnership combines Jio’s strong digital presence in India with Allianz’s global expertise in underwriting and reinsurance, the companies said in a joint statement on Friday. In addition, both parties signed a non-binding agreement to explore setting up general and life insurance businesses in the country, also under an equal ownership model. This move marks another step in Ambani’s push into financial services. Jio Financial already operates in digital banking and recently announced an asset management joint venture with BlackRock Inc. The new reinsurance venture will begin operations once it obtains the necessary regulatory approvals. The announcement comes after Allianz exited its earlier partnerships with Bajaj Finserv Ltd in India. With insurance penetration in India still relatively low at around 3.7% of GDP — compared to other Asian markets like Japan and South Korea — the new venture aims to tap into a growing market with significant potential.

Investment & Market Trends

Apollo Secures Bid for Singapore’s US$1 Billion Private Credit Fund

SINGAPORE, Apollo Global Management has been awarded the mandate to manage Singapore’s S$1 billion (US$778.3 million) Private Credit Growth Fund, which targets high-growth local enterprises, according to information published on a government procurement portal. Launched in March by the Ministry of Trade and Industry (MTI) and Enterprise Singapore, the fund aims to provide non-dilutive and customised financing to support the expansion of local enterprises with strong growth potential. Further details about the fund are expected to be announced in the third quarter of this year. First introduced during the national Budget 2024 speech, the Private Credit Growth Fund forms part of Singapore’s broader efforts to strengthen its position in the US$1.7 trillion global private debt market. The fund seeks to address financing gaps for local businesses while fostering a more vibrant and diversified capital market landscape. The move complements other private market initiatives, including the Monetary Authority of Singapore’s (MAS) consultation in March on a proposed regulatory framework aimed at opening private market access to retail investors—subject to adequate investor protection measures. In parallel, Temasek Holdings, Singapore’s sovereign wealth fund, has also deepened its involvement in the asset class. In December, it launched a private credit platform with an initial portfolio of approximately US$10 billion in direct investments and credit funds. Additionally, Temasek’s subsidiary SeaTown Holdings International raised US$1.3 billion last year for its second private credit fund. The appointment of Apollo—renowned for its expertise in alternative investments—signals a major step in advancing Singapore’s ambitions to become a regional hub for private credit and alternative financing.

Investment & Market Trends

CIMB and Pharmaniaga Forge Strategic Alliance to Strengthen Financial Flexibility for Healthcare SMEs

KUALA LUMPUR, CIMB Bank Berhad has entered into a strategic collaboration with Pharmaniaga Logistics Sdn Bhd, a wholly owned subsidiary of Pharmaniaga Berhad, to enhance supply chain financing and improve payment flexibility for small and medium enterprises (SMEs) in the healthcare industry. This partnership is set to benefit clinics, pharmacies, and medical suppliers by offering greater financial agility, CIMB announced in a statement today. (From left) Gurdip Singh Sidhu, Chief Executive Officer, CIMB Malaysia and CIMB Bank Berhad, Lawrence Loh, Co-Chief Executive Officer, Group Commercial and Transaction Banking, CIMB Group, Ahmad Shahredzuan Mohd Shariff, Chief Operating Officer, Pharmaniaga Bernad and Zulkil Jatar, Managing Director, Pharmaniaga Berhad at the Mou signing to enhance supply chain financing and payment flexibility for healthcare SMEs, including clinics, pharmacies and medical buyers. Under the collaboration, CIMB and Pharmaniaga will offer flexible payment solutions to downstream buyers—including private clinics and independent pharmacies—through the CIMB SME BusinessCard. Cardholders will enjoy extended credit terms of up to 50 days on medical supply purchases, alongside an unlimited 0.5% cashback on all transactions made with Pharmaniaga. These benefits aim to optimise working capital and improve cash flow for healthcare providers. Lawrence Loh, Co-CEO of Group Commercial and Transaction Banking at CIMB Group, said the initiative is designed to ease the financial burden faced by healthcare SMEs while enabling them to deliver better patient care. “Through extended credit terms and early settlement incentives, we are supporting clinics, pharmacies, and other healthcare buyers in managing operational costs more effectively,” he said. “This collaboration reflects our commitment to expanding our healthcare SME portfolio by working closely with ecosystem partners and providing tailored, digital-first financing solutions.” Pharmaniaga Managing Director Zulkifli Jafar echoed these sentiments, emphasising the company’s dedication to supporting its partners with practical financial tools. “This partnership underscores our ongoing commitment to strengthening our supply chain ecosystem,” he said. “By offering enhanced payment flexibility and customised financing, we aim to empower our partners to grow sustainably while ensuring consistent access to essential pharmaceutical products.” The collaboration marks a significant step toward improving financial resilience and operational efficiency within Malaysia’s healthcare SME sector.

Investment & Market Trends

Japanese Giant Mitsubishi Invests US$988 Million to Expand Global Salmon Production

Japanese trading giant Mitsubishi has announced a significant expansion of its salmon farming portfolio through the acquisition of businesses in Norway and Canada, underlining its commitment to strengthening its foothold in the global food sector with an emphasis on protein. Amid volatile fossil fuel markets and the pursuit of stable revenue streams, Mitsubishi and other Japanese conglomerates have increasingly diversified into the food industry, anticipating sustained demand driven by global population growth. “Securing food resources has become a critical global challenge in recent years, propelled by population increases,” Mitsubishi stated. The acquisition, valued at 10.2 billion Norwegian crowns (US$988.3 million), involves three companies owned by Norwegian seafood producer Grieg Seafood ASA. The deal was executed through Cermaq Group, Mitsubishi’s salmon farming subsidiary with existing operations in Norway, Canada and Chile. The move is set to raise Cermaq’s annual salmon production from its current level of approximately 200,000 tonnes to an estimated 280,000 tonnes by fiscal 2027, positioning the group as a key player in the industry. Salmon remains one of the most popular sushi ingredients in Japan, yet the majority of supplies are imported from countries such as Norway and Chile. In response, Japan has set a target to increase the proportion of locally sourced seafood it consumes to 94 per cent by 2033, from 54 per cent at present. In a similar development, Marubeni began marketing salmon last October from a farm operated near Mount Fuji in partnership with a Norwegian company, adding to the growing seafood ventures where competitors Mitsubishi and Mitsui are also active. -Reuters

Investment & Market Trends

Maybank Singapore and SCCCI Partner to Advance JS-SEZ Investments

Maybank Singapore Ltd has entered into a memorandum of understanding with the Singapore Chinese Chamber of Commerce and Industry to enhance cross-border business collaboration and drive investments with a strategic focus on the Johor-Singapore Special Economic Zone. In a joint statement, the parties said the collaboration aims to promote economic development, investment and trade between the two countries. The partnership will see both organisations jointly organise meetings, visits, conferences, workshops and networking events while introducing new initiatives to advance shared objectives. Maybank will offer tailored solutions to businesses, including green lane financing, trade finance, cash management and ESG-linked products, as well as facilitate faster account onboarding. Members of the Chamber will also gain access to capacity-building programmes in areas such as sustainability, Halal advisory and financial services, supported by dedicated advisory services from Maybank’s Johor-Singapore Special Economic Zone Desk. The agreement is expected to benefit approximately 5,000 corporate members of the Chamber. SCCCI president Kho Choon Keng said the combination of the Chamber’s extensive business network with Maybank’s financial strength would enable members and local businesses to access cross-border financing, build ESG competencies and gain valuable market insights. He added that the partnership would open new economic opportunities and help businesses succeed in Malaysia and across Southeast Asia. Maybank Singapore chief executive officer Alvin Lee Han Eng highlighted the bank’s dual-market advantage in Singapore and Malaysia as one of the earliest proponents of the Johor-Singapore Special Economic Zone. He said Maybank is committed to supporting businesses with a comprehensive suite of banking solutions while identifying twinning opportunities for expansion into the zone. -The Star

Investment & Market Trends

Huawei Reclaims Leadership in China’s Smartphone Market

Huawei has regained its position as the leading smartphone maker in China for the first time in over four years, surpassing US rival Apple and domestic brands including Xiaomi, according to data from the US-based International Data Corporation (IDC). The Shenzhen-based technology giant captured an 18.1 per cent share of China’s smartphone market in the second quarter of this year, with shipments reaching 12.5 million units, IDC reported on Tuesday. Huawei’s resurgence comes despite years of pressure from US export controls, Western bans, and a graft investigation in Belgium. The company has been at the centre of geopolitical tensions between the world’s two largest economies after Washington alleged its equipment could be used for espionage by Beijing, a charge the company has repeatedly denied. China’s broader smartphone market contracted after six consecutive quarters of growth. IDC data showed total shipments fell four per cent year on year to 69 million units in the second quarter. “Despite the recent US-China trade truce, the broader economic environment presents ongoing challenges, with consumer confidence remaining subdued,” said Arthur Guo, senior research analyst at IDC. “This suggests that a significant uplift in smartphone demand is unlikely in the immediate term, and the market will navigate a more complex landscape in the second half of the year.” Apple, meanwhile, experienced a slowdown in iPhone sales in China and last year lost its title as the country’s best-selling smartphone brand to two local competitors. The California-based firm ranked fifth in the IDC report, with a 13.9 per cent market share and 9.6 million units shipped. China’s economy expanded by more than five per cent in the second quarter, according to official data, even as the fallout from tariff disputes with the United States weighed on consumer sentiment. -AFP

Investment & Market Trends, News

PNB Ranked Malaysia’s Top Sovereign Investor and Climbs to 17th Globally

Permodalan Nasional Bhd (PNB) has been named Malaysia’s leading sovereign investor and ranked 17th globally in the 2025 Governance, Sustainability and Resilience (GSR) Scoreboard released by United States-based research firm Global SWF. The GSR Scoreboard is widely regarded as a benchmark for best practices among state-owned investors worldwide, assessing over 200 sovereign wealth funds (SWF) and public pension funds on governance standards, sustainability commitments and institutional resilience. In its statement today, PNB reported an overall score of 84 per cent, achieving a perfect 10 out of 10 in the sustainability category. This accolade reflects recognition for its climate targets, environmental, social and governance (ESG) integration, and transparency in reporting. “This ranking highlights the significant progress PNB has made in strengthening governance, embedding sustainability throughout its investment processes and enhancing long-term institutional resilience,” the fund said. PNB Deputy President and Group Chief Executive Datuk Rick Ramli noted the achievement underscores the organisation’s efforts to embed responsible and sustainable practices across its operations and investment activities. “It is also a strong encouragement for us to continue driving long-term value creation for our unit holders and the broader Malaysian economy, consistent with PNB’s purpose of uplifting the financial lives of Malaysians across generations,” he said. PNB reported notable progress towards its climate goals, including a 98 per cent reduction in Scope 1 and 2 emissions from its 2022 baseline, supporting its ambition to achieve net zero operations by 2025. At the portfolio level, the fund aims to reach a net-zero investment portfolio by 2050 and has already channelled RM5.5 billion into green and transition assets, representing 55 per cent of its RM10 billion target by 2030. Since 2023, PNB has implemented a living wage policy for its employees and is actively encouraging its investee companies to adopt similar practices under the government’s GEARuP initiative. -Bernama

Investment & Market Trends

Hartalega Faces Earnings Pressure as Analysts Slash FY26 Forecast

Hartalega Holdings Bhd is expected to deliver lower earnings for the financial year ending 31 March 2026 (FY26), as analysts revise their forecasts downward in light of margin compression and foreign exchange (forex) headwinds. Kenanga Research has reduced its FY26 net profit projection for Hartalega by 25%, driven primarily by a downward revision in earnings margin assumptions. The research house now anticipates a margin of 12%, down from its previous estimate of 14%, citing conservative assumptions that the company will not immediately pass on forex-related cost pressures to customers. Reflecting this revised outlook, Kenanga has adjusted its target price for the stock from RM4.00 to RM3.20, applying a lower valuation multiple of 2.5 times FY26 book value per share (BVPS), compared with 2.9 times previously. This move accounts for the expected near-term impact of forex movements on the group’s profitability. In its report to clients, Kenanga also noted that Hartalega’s significant exposure to the United States market—where sales comprise between 50% and 60% of total revenue—could be adversely affected if the currently high tariffs imposed on Chinese glove manufacturers are relaxed. The potential easing of these tariffs could diminish any near-term market share gains Hartalega might otherwise realise in the US. Despite these challenges, Kenanga believes Hartalega’s share price is currently trading at a level that aligns with its historical price-to-book valuation range before the imposition of US tariffs on Chinese competitors in September 2024. At that time, the stock traded between 1.8 to 2.0 times PBV. On a two-times FY26 BVPS basis, the stock should be valued at approximately RM2.50 per share. At last close, Hartalega’s shares were trading at RM1.55. The company’s financial performance for FY25 saw a significant rebound, with net profit rising fivefold to RM74.5 million. While this was in line with Kenanga’s expectations, it came in 12% below the consensus forecast. During a recent briefing, management indicated that it anticipates a modest increase in sales volume for the first quarter of FY26, with growth of between 1% and 8% quarter-on-quarter. This translates to a volume range of six billion to 6.6 billion pieces, as customers reportedly remain cautious amid ongoing uncertainty surrounding tariffs and opt to rely on existing inventories rather than initiate restocking. As a case in point, shipments surged to 2.3 billion pieces in May before retreating to two billion pieces in June. However, Hartalega expects inventory replenishment to resume in the second half of FY26, with improved order visibility beginning from June this year. -The Star

Investment & Market Trends

NTT DC REIT’s Tepid SGX Debut Follows Singapore’s Largest IPO Since 2021

NTT DC REIT, the data centre real estate investment trust backed by Japan’s Nippon Telegraph and Telephone Corporation (NTT), made a subdued debut on the Singapore Exchange (SGX) on Monday, despite raising US$773 million in the city-state’s largest initial public offering (IPO) since 2021. The units opened modestly at US$1.03 within the first 30 minutes of trading, edging just above the offer price of US$1.00. The STI benchmark index was up 0.4 per cent during the same period. NTT DC REIT holds a portfolio of six data centres located in Austria, Singapore and the United States, with a total valuation of approximately US$1.6 billion. The trust’s cornerstone investors include Singapore’s sovereign wealth fund GIC, which holds a 9.8 per cent stake, making it the second-largest stakeholder after NTT Ltd, which retains 25 per cent. The listing highlights increasing global investor appetite for data centre assets across Asia-Pacific, underpinned by accelerating demand for artificial intelligence infrastructure and services. This IPO marks Singapore’s most substantial listing since Digital Core REIT’s US$977 million debut in 2021, according to data from LSEG. It also stands as Southeast Asia’s largest IPO since Thai Life Insurance raised US$942.9 million in 2022. Expanding IPO Pipeline in Singapore The SGX has seen renewed listing activity following the rollout of market-strengthening initiatives in February, including a 20 per cent corporate tax rebate for companies pursuing primary listings. “There is a broad base of potential REIT IPOs on the horizon, including data centre, industrial, logistics, hospitality, commercial and retail assets,” said Art Karoonyavanich, Global Head of Equity Capital Markets at DBS. “This marks the first time we have such a pipeline within a 12-month horizon, and these IPOs could raise anywhere between S$600 million (US$468.27 million) and S$1 billion.” Beyond REITs, China Medical System (CMS), listed in Hong Kong, is set to commence trading on the SGX on Tuesday via a secondary listing. “We believe that upon completion of the proposed secondary listing on the SGX, CMS will be able to attract funds focusing on Asia-Pacific investments and local capital in Southeast Asia, thereby optimising the shareholder structure,” the company said in a statement to Reuters. Other listing candidates in Singapore include Foundation Healthcare and Centurion, which plans to launch a REIT focused on employee dormitory assets. The uptick in listing activity comes amid a buoyant stock market. Singapore’s benchmark index has climbed more than 8 per cent since the beginning of the year and reached record highs in the past nine trading sessions, according to LSEG data. -Reuters

Scroll to Top

Subscribe
FREE Newsletter